Mark Auerbach
Nessuna posizione attualmente
Profilo
Mark Auerbach served as Chairman, President, Chief Executive Officer & CFO at Sterling Infrastructure, Inc. from 1995 to 1997.
He was also Executive Chairman at Endo Generics Holdings, Inc. and Non-Executive Chairman at Par Pharmaceutical, Inc. in 2006.
From 2006 to 2010, he served as Chairman at Woodbrook Group Holdings, Inc. He was a Director at RxElite, Inc., Ventrus Biosciences, Inc., RxElite Holdings, Inc., and Collexis Holdings, Inc. He also served as Lead Independent Director at Optimer Pharmaceuticals LLC from 2005 to 2013.
Since 2010, he has been an Independent Director at Assembly Biosciences, Inc. and is currently an Independent Director at Pardes Biosciences, Inc. He was previously the Chief Financial Officer & Senior Vice President at Central Lewmar LP from 1993 to 2005.
He also worked as a Partner at Masco Associates, Inc. Mr. Auerbach received his undergraduate degree from Rider University.
Precedenti posizioni note di Mark Auerbach
| Società | Posizione | Fine |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Chairman | 01/03/2022 |
| ASSEMBLY BIOSCIENCES, INC. | Director/Board Member | 11/06/2020 |
| RCS CAPITAL CORP | Chairman | 01/06/2016 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Director/Board Member | 24/10/2013 |
| WOODBROOK GROUP HOLDINGS INC. | Chairman | 31/03/2010 |
Formazione di Mark Auerbach
| Rider University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| STERLING INFRASTRUCTURE, INC. | Industrial Services |
| RXELITE, INC. | Health Technology |
| WOODBROOK GROUP HOLDINGS INC. | Finance |
| COLLEXIS HOLDINGS INC. | Technology Services |
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| Aziende private | 9 |
|---|---|
Endo Generics Holdings, Inc.
 Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Ventrus Biosciences, Inc.
 Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ventrus Biosciences, Inc. is a development stage specialty pharmaceutical company engages in development of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoidal disease, anal fissures, and fecal incontinence. Its major pharmaceutical progress made in the gastrointestinal therapeutic areas of gastroesophageal reflux, peptic ulcer disease, and inflammatory bowel disease. Ventrus Biosciences products includes VEN 307 (topical diltiazem), is intended to treat pain associated with anal fissures and VEN 308 (topical phenylephrine), is intended to treat fecal incontinence. The company was founded on October 10, 2005 and is headquartered in New York, NY. | Health Technology |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
Par Pharmaceutical, Inc.
 Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
Central Lewmar LP
 Central Lewmar LP Wholesale DistributorsDistribution Services Part of International Paper Co., Central Lewmar LP is a distributor of paper products and packaging materials and equipment. The private company is based in Westampton, NJ. Central Lewmar was acquired by Central Lewmar LLC on December 16, 2005. | Distribution Services |
RxElite Holdings, Inc.
 RxElite Holdings, Inc. Pharmaceuticals: MajorHealth Technology RxElite Holdings, Inc. develops and manufactures generic prescription drug products. The company was founded by Jonathan Houssian in 2000 and is headquartered in Meridian, ID. | Health Technology |
| Masco Associates, Inc. | |
Aretec Group, Inc.
 Aretec Group, Inc. Investment Banks/BrokersFinance Aretec Group, Inc. is a holding company, which engages in the provision of integrated financial services focusing on retail investors. The company was founded on December 27, 2012 and is headquartered in El Segundo, CA. | Finance |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA. | Health Technology |
- Borsa valori
- Insiders
- Mark Auerbach
